Description
Citomoxan (Moxifloxacin Hydrochloride) Eye Drops 0.5% 5 mg. №1
Composition
Active Ingredient: Moxifloxacin hydrochloride 5 mg per 1 ml.
Mechanism of Action
Pharmacological Properties: Moxifloxacin, a fluoroquinolone antibiotic, exerts its action by inhibiting bacterial DNA gyrase and topoisomerase IV enzymes, leading to the disruption of DNA replication and transcription, ultimately causing bacterial cell death.
Indications for Use
Indications: Citomoxan eye drops are indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of microorganisms.
Contraindications
Contraindications: Do not use in patients with a history of hypersensitivity to moxifloxacin or any other components of the formulation.
Side Effects
Common side effects may include eye irritation, burning, or stinging sensation. If any severe reactions occur, discontinue use and seek medical advice.
Usage Instructions
Dosage: Instill 1 drop in the affected eye(s) every 4-6 hours for the first 2 days, then reduce to 1 drop 2-3 times daily.
Directions: Wash hands before use. Tilt the head back, pull the lower eyelid down, and instill the prescribed number of drops. Close the eye for a few minutes without blinking.
Benefits Compared to Analogues
Citomoxan eye drops containing moxifloxacin have demonstrated superior efficacy in treating bacterial conjunctivitis compared to traditional antibiotics. The targeted mechanism of action results in rapid symptom relief and improved patient outcomes.
Suitable Patient Groups
This product is suitable for use in both adult and pediatric populations. Dosage adjustments may be necessary based on individual patient characteristics and severity of the infection.
Storage and Shelf Life
Store Citomoxan eye drops in a cool, dry place away from direct sunlight. Ensure the container is tightly closed. The shelf life of the product is as indicated on the packaging.
Packaging Description
The product is packaged in a sterile container designed for ophthalmic use. Each unit contains a specified volume of the solution with clear labeling of the active ingredient concentration.
Clinical Evidence and Proven Effectiveness
Clinical studies have shown that Citomoxan eye drops provide rapid relief of symptoms associated with bacterial conjunctivitis and have a favorable safety profile. Patients treated with moxifloxacin eye drops experienced a significant improvement in signs and symptoms compared to placebo.
